by Touch Stone Publishers | May 11, 2026
The Federal Reserve’s May 2026 Financial Stability Report confirms hedge fund gross notional leverage near record levels, concentrated in the largest funds, while life insurer leverage holds in the top quartile of its historical range, both against a backdrop of...
by Touch Stone Publishers | May 9, 2026
In November 2025, the Securities and Exchange Commission made a decision that fundamentally reshapes how corporate boards govern shareholder proposals. The Division of Corporation Finance suspended its historic review of shareholder proposal exclusion decisions,...
by Touch Stone Publishers | Apr 24, 2026
On April 2, 2026, President Trump issued a Proclamation invoking Section 232 of the Trade Expansion Act of 1962 to impose a 100 percent ad valorem tariff on patented pharmaceutical imports and active pharmaceutical ingredients. The tariff becomes effective July 31,...
by Touch Stone Publishers | Apr 23, 2026
On April 2, 2026, President Trump issued a proclamation imposing tariffs up to 100 percent on patented pharmaceuticals and active pharmaceutical ingredients (APIs) under Section 232 of the Trade Expansion Act of 1962. The tariffs take effect July 31, 2026 (for major...
by Touch Stone Publishers | Apr 21, 2026
President Trump’s April 2, 2026, Proclamation under Section 232 of the Trade Expansion Act of 1962 establishes a 100 percent ad valorem tariff on patented pharmaceutical products and their associated active pharmaceutical ingredients (APIs) imported into the...
by Touch Stone Publishers | Apr 21, 2026
President Trump’s April 2, 2026, Proclamation under Section 232 of the Trade Expansion Act of 1962 establishes a 100 percent ad valorem tariff on patented pharmaceutical products and their associated active pharmaceutical ingredients (APIs) imported into the...
